TeraRecon unveils lung density analysis for COVID-19

2020 02 29 03 03 9414 Terarecon Rsna 2019 400

Advanced visualization and artificial intelligence (AI) software developer TeraRecon has introduced two new lung density analysis software applications to aid in the assessment and follow-up care of patients with COVID-19.

Lung Density Analysis II (LDA-II) enables TeraRecon's Intuition customers to upgrade their advanced visualization software to include a custom lung workflow. Making use of Intuition's lung segmentation, volumetric histogram analysis, and automation capabilities, LDA-II provides physicians with colorized densities and lung composition values that can be analyzed and quantified with little to no manual editing, the company said.

Current Intuition customers can access LDA-II via a remotely installed upgrade. The software is also included with a subscription to the firm's Intuition Titanium Suite.

The second new offering, Emergency Lung AI Suite, is designed to provide fast access to lung density analysis tools across the enterprise and to physicians working remotely, according to the vendor. A cloud-based platform, Emergency Lung AI Suite enables physicians to upload cases, anonymize patient data, process the LDA-II algorithm, and be notified of results.

No installation is required, and the software can be quickly integrated with diagnostic and point-of-care software applications. Emergency Lung AI Suite can also be extended to other clinical use cases within a health system's imaging and crisis readiness infrastructure, TeraRecon said.

Page 1 of 110
Next Page